Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Polonsky

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
BMC Family Practice|May 21, 2010
The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986]William Polonsky, Lawrence Fisher, Charles Schikman, et al.
Journal of Diabetes Science and Technology|April 16, 2016
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)Marcus Lind, William Polonsky, Irl B Hirsch, et al.
Diabetes Technology & Therapeutics|September 15, 2021
Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 DiabetesStephanie Edwards, Xuanyao He, Wenjie Wang, et al.
Canadian Journal of Diabetes|February 21, 2025
ResponseMichael Vallis, Lori Berard, Emmanuel Cosson, et al.
Canadian Journal of Diabetes|July 21, 2024
Promoting Self-Management in Adults With Type 2 Diabetes: Development of the Impact of Glucose Monitoring on Self-Management ScaleMichael Vallis, Lori Berard, Emmanuel Cosson, et al.
Diabetes, Obesity & Metabolism|April 1, 2020
Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)Esteban Jódar, Marie Michelsen, William Polonsky, et al.
Diabetes Research and Clinical Practice|October 5, 2024
Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1William Polonsky, Malik Benamar, Lisbeth Carstensen, et al.
Canadian Journal of Diabetes|April 12, 2023
How Continuous Glucose Monitoring Can Motivate Self-management: Can Motivation Follow Behaviour?Michael Vallis, Hana Ryan, Lori Berard, et al.
Primary Care Diabetes|March 2, 2019
Diabetes and depression were not associated in Venezuelan adults: The EVESCAM study, a national cross-sectional sampleJuan Pablo González-Rivas, William Polonsky, María María Infante-García, et al.
Diabetes Care|November 17, 2020
Sustained Intensive Treatment and Long-term Effects on HbA<sub>1c</sub> Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDIMarcus Lind, Arndís F Ólafsdóttir, Irl B Hirsch, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
BMC Family Practice|May 21, 2010
The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986]William Polonsky, Lawrence Fisher, Charles Schikman, et al.
Journal of Diabetes Science and Technology|April 16, 2016
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)Marcus Lind, William Polonsky, Irl B Hirsch, et al.
Diabetes Technology & Therapeutics|September 15, 2021
Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 DiabetesStephanie Edwards, Xuanyao He, Wenjie Wang, et al.
Canadian Journal of Diabetes|February 21, 2025
ResponseMichael Vallis, Lori Berard, Emmanuel Cosson, et al.
Canadian Journal of Diabetes|July 21, 2024
Promoting Self-Management in Adults With Type 2 Diabetes: Development of the Impact of Glucose Monitoring on Self-Management ScaleMichael Vallis, Lori Berard, Emmanuel Cosson, et al.
Diabetes, Obesity & Metabolism|April 1, 2020
Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)Esteban Jódar, Marie Michelsen, William Polonsky, et al.
Diabetes Research and Clinical Practice|October 5, 2024
Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1William Polonsky, Malik Benamar, Lisbeth Carstensen, et al.
Canadian Journal of Diabetes|April 12, 2023
How Continuous Glucose Monitoring Can Motivate Self-management: Can Motivation Follow Behaviour?Michael Vallis, Hana Ryan, Lori Berard, et al.
Primary Care Diabetes|March 2, 2019
Diabetes and depression were not associated in Venezuelan adults: The EVESCAM study, a national cross-sectional sampleJuan Pablo González-Rivas, William Polonsky, María María Infante-García, et al.
Diabetes Care|November 17, 2020
Sustained Intensive Treatment and Long-term Effects on HbA<sub>1c</sub> Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDIMarcus Lind, Arndís F Ólafsdóttir, Irl B Hirsch, et al.
Pageof 5